Literature DB >> 9049929

Correction of hyperopia induced by photorefractive keratectomy using non-contact Ho:YAG laser thermal keratoplasty.

J L Alió1, M M Ismail, A Artola, J J Pérez Santonja.   

Abstract

PURPOSE: To evaluate the safety and effectiveness of non-contact holmium:YAG laser thermal keratoplasty in correcting hyperopia induced by photorefractive keratectomy (PRK).
METHODS: Non-contact holmium:YAG laser thermal keratoplasty was applied to 14 eyes with significant hyperopia induced by PRK. The mean spherical equivalent refraction before holmium:YAG laser thermal keratoplasty was +4.20 +/- 1.80 diopters (D) (range, +1.75 to +6.25 D). The results were evaluated 12 months after holmium:YAG laser thermal keratoplasty.
RESULTS: No sight-threatening complications occurred. Recovery of spectacle-corrected visual acuity took from 2 to 6 weeks. The immediate significant myopic shift that developed in all eyes gradually receded over 6 to 8 weeks. All eyes were relatively stable after 9 months. At 12 months, there was no statistically significant difference (p < .005) between the mean preoperative spectacle-corrected visual acuity (0.71 +/- 0.12) and the mean postoperative uncorrected visual acuity (0.65 +/- 0.28). At 12 months there was a mean increase of 4.60 +/- 1.20 D in central keratometric power. Total regression did not occur in any eye.
CONCLUSIONS: Non-contact holmium:YAG laser thermal keratoplasty offers a safe and effective alternative to correct PRK-induced hyperopia.

Entities:  

Mesh:

Year:  1997        PMID: 9049929     DOI: 10.3928/1081-597X-19970101-06

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  Conductive keratoplasty for the correction of hyperopia.

Authors:  P A Asbell; R K Maloney; J Davidorf; P Hersh; M McDonald; E Manche
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  Ring electrode for radio-frequency heating of the cornea: modelling and in vitro experiments.

Authors:  E J Berjano; J Saiz; J L Alió; J M Ferrero
Journal:  Med Biol Eng Comput       Date:  2003-11       Impact factor: 2.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.